title: Cochrane corner: early statin therapy in acute coronary syndromes--what is the clinical benefit?
authors.affiliation: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland.
authors.forename: Alain
authors.initials: A
authors.lastname: Nordmann
authors.affiliation: VA Medical Center and University of Colorado, Denver, Colorado, USA.
authors.forename: Gregory
authors.initials: G
authors.lastname: Schwartz
authors.affiliation: Private Practice in Family Medicine, Toronto, Canada.
authors.forename: Noah
authors.initials: N
authors.lastname: Vale
authors.affiliation: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland.
authors.forename: Heiner C
authors.initials: HC
authors.lastname: Bucher
authors.affiliation: Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada.
authors.forename: Matthias
authors.initials: M
authors.lastname: Briel
mesh_terms: D000789:Angina, Unstable / Q000188:drug therapy*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D005260:Female; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D011758:Pyrroles / Q000627:therapeutic use*
chemical_list: D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles